Open post

1st General Assembly Meeting

TransQST GAM1 took place in Vihti (Finland) in April 2018

The first General Assembly meeting, GAM1, took place on the 25th and 26th of April 2018, in Vihti at Orion Tuohilampi Training Center (Finland). This 2-day meeting was organized as follows: Day 1 – paralel meetings of Organ related WPs with representatives of WP3 (data) and WP4 (modelling), and Day 2 – whole consortium meeting […] Read moreMore Tag

Open post

UOXF TransQST colleagues won the 2017 NC3Rs Prize

An in silico model that predicts cardiotoxicity awarded in March 2018

On the 12th of March 2018, the National Centre for the 3Rs (NC3Rs) – an organisation dedicated to replacing, refining and reducing the use of animals in research and testing – has awarded its top prize for a research paper on an in silico model that predicts cardiotoxicity developed and reported by the TransQST team […] Read moreMore Tag

Open post

Boehringer Ingelheim joins the TransQST consortium

Boehringer Ingelheim has joined the consortium, effective since July 2017

The Boehringer Ingelheim (BI) pharmaceutical company made a formal proposal to join the TransQST consortium in June 2017. The TransQST partners found their addition to be an excellent opportunity to complement and extend the coverage of the modeling framework within the particular area of GI toxicity assessment (WP8). SYNAPSE has coordinated the documentation preparation between […] Read moreMore Tag

Open post

2nd Workshop

TransQST 2nd Workshop took place in Ludwigshafen (Germany) in September 2017

The 2nd workshop took place on the 28th and 29th of September 2017, in Ludwigshafen at AbbVie premises (Germany). This workshop was scheduled as follow up on the 1st Workshop, January 2017. The goals of this 2nd workshop were focused on the evaluation that all WPs have been doing during these early months of the […] Read moreMore Tag

Open post

EAB and SAB members

TransQST announces the Ethics and Scientific Advisory Boards members in July 2017

The TransQST consortium is pleased to announce the members of the TransQST Ethics Advisory Board (EAB) and the TransQST Scientific Advisory Board (SAB). To achieve the TransQST objectives, the consortium will use pre-existing data wherever possible but will, on occasion, require access to human/animal biofluid samples and tissue biopsies in order to back-fill data gaps […] Read moreMore Tag

Open post

WP5-WP6 Meeting

TransQST WP5-WP6 Meeting was held in Leiden (the Netherlands) in March 2017

WP5 and WP6 joint for a meeting hosted by the University of Leiden on the 24th of March 2017. Representatives of both work packages discussed on the understanding of how and what a multi-scale model is for the Liver (WP5) or Kidney (WP6) organs. This first face-to-face meeting was organized to develop a Roadmap for […] Read moreMore Tag

Open post

Kick off meeting

TransQST kick off Meeting was held in Barcelona (Spain) in January 2017

The Kick off Meeting of the TransQST project took place on the 23rd and 24th of January 2017 in the city of Barcelona, and counted with the attendance of the representatives of the whole Consortium. The new European five-year research project, Translational Quantitative Systems Toxicology to improve the understanding of the safety medicines (TransQST), was launched […] Read moreMore Tag

Open post

News Release

€16M cash boost for adverse drug reaction research

A new European research project has been launched which aims to improve the understanding of adverse drug reactions (ADR) and the approach of systems modelling approaches to drug safety. A new €16m European research project has been launched which aims to improve the understanding of adverse drug reactions and the approach of systems modelling approaches […] Read moreMore Tag